These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 7489229
21. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR. Obstet Gynecol; 1990 Feb; 75(2):217-22. PubMed ID: 2300348 [Abstract] [Full Text] [Related]
22. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Oyelola OO. Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671 [Abstract] [Full Text] [Related]
23. Social instability and coronary artery atherosclerosis in cynomolgus monkeys. Manuck SB, Kaplan JR, Clarkson TB. Neurosci Biobehav Rev; 1983 May; 7(4):485-91. PubMed ID: 6686877 [Abstract] [Full Text] [Related]
25. Aspirin inhibits development of coronary atherosclerosis in cynomolgus monkeys (Macaca fascicularis) fed an atherogenic diet. Pick R, Chediak J, Glick G. J Clin Invest; 1979 Jan; 63(1):158-62. PubMed ID: 105014 [Abstract] [Full Text] [Related]
26. Oral contraceptives, lipoproteins, and atherosclerosis. Adams MR, Clarkson TB, Shively CA, Parks JS, Kaplan JR. Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963 [Abstract] [Full Text] [Related]
27. Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Hamm TE, Kaplan JR, Clarkson TB, Bullock BC. Atherosclerosis; 1983 Sep; 48(3):221-33. PubMed ID: 6685520 [Abstract] [Full Text] [Related]
28. Influence of a levonorgestrel-containing contraceptive vaginal ring on plasma lipids and lipoproteins in cynomolgus monkeys. Adams MR, Rudel LL, Clarkson TB, Nelson CA, Thau RB, Moo-Young AJ. Contraception; 1983 Sep; 28(3):253-66. PubMed ID: 6416747 [Abstract] [Full Text] [Related]
29. Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys. Adams MR, Anthony MS, Manning JM, Golden DL, Parks JS. Obstet Gynecol; 2000 Aug; 96(2):250-5. PubMed ID: 10908772 [Abstract] [Full Text] [Related]
30. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J. Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638 [Abstract] [Full Text] [Related]
31. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins. Kruszon-Moran D, Burkman RT, Kimball AW, Bachorik PS, Gold EB. Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983 [Abstract] [Full Text] [Related]
33. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle. Moller SE, Moller BM, Olesen M, Fjalland B. Eur J Clin Pharmacol; 1996 Jan; 50(3):179-84. PubMed ID: 8737756 [Abstract] [Full Text] [Related]
34. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel. Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB. Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055 [Abstract] [Full Text] [Related]
35. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H. Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262 [Abstract] [Full Text] [Related]